149 related articles for article (PubMed ID: 35128977)
1. Seroprevalence of Anti-SARS-CoV-2 IgG Antibodies among HIV Infected Individuals Attending ART Centre at Pune: A Cross-Sectional Study.
Ghate M; Shidhaye P; Gurav S; Gadhe K; Kale V; Jain P; Thakar M
J Int Assoc Provid AIDS Care; 2022; 21():23259582221077943. PubMed ID: 35128977
[No Abstract] [Full Text] [Related]
2. HIV and SARS-CoV-2 co-infection: cross-sectional findings from a German 'hotspot'.
Noe S; Schabaz F; Heldwein S; Mayer W; Ruecker K; Tiller FW; von Krosigk A; Wiese C; Balogh A; Gersbacher E; Jonsson-Oldenbuettel C; Jaeger H; Wolf E;
Infection; 2021 Apr; 49(2):313-320. PubMed ID: 33387261
[TBL] [Abstract][Full Text] [Related]
3. Pre-existing immunity to SARS-CoV-2 before the COVID-19 pandemic era in Cameroon: A comparative analysis according to HIV-status.
Aissatou A; Fokam J; Semengue ENJ; Takou D; Ka'e AC; Ambe CC; Nka AD; Djupsa SC; Beloumou G; Ciaffi L; Tchouaket MCT; Nayang ARM; Pabo WLT; Essomba RG; Halle EGE; Okomo MC; Bissek AZ; Leke R; Boum Y; Mballa GAE; Montesano C; Perno CF; Colizzi V; Ndjolo A
Front Immunol; 2023; 14():1155855. PubMed ID: 37090738
[TBL] [Abstract][Full Text] [Related]
4. IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
Kaddu-Mulindwa D; Keuser L; Lesan V; Rissland J; Smola S; Werdecker V; Stilgenbauer S; Christofyllakis K; Thurner L; Bewarder M; Lohr B; Lutz J; Lohse S; Rieke A
HIV Med; 2022 May; 23(5):564-569. PubMed ID: 34811869
[TBL] [Abstract][Full Text] [Related]
5. Seroprevalence of SARS-CoV-2 specific Immunoglobin G antibodies in rural population of Western Maharashtra, India.
Agarwal D; Patil R; Roy S; Kaur H; Mehandale S; Bavdekar A; Nair H; Juvekar S; Dayma G;
J Glob Health; 2023 Apr; 13():06011. PubMed ID: 37079274
[TBL] [Abstract][Full Text] [Related]
6. SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey.
Murhekar MV; Bhatnagar T; Selvaraju S; Saravanakumar V; Thangaraj JWV; Shah N; Kumar MS; Rade K; Sabarinathan R; Asthana S; Balachandar R; Bangar SD; Bansal AK; Bhat J; Chopra V; Das D; Deb AK; Devi KR; Dwivedi GR; Khan SMS; Kumar CPG; Kumar MS; Laxmaiah A; Madhukar M; Mahapatra A; Mohanty SS; Rangaraju C; Turuk A; Baradwaj DK; Chahal AS; Debnath F; Haq I; Kalliath A; Kanungo S; Kshatri JS; Lakshmi GGJN; Mitra A; Nirmala AR; Prasad GV; Qurieshi MA; Sahay S; Sangwan RK; Sekar K; Shukla VK; Singh PK; Singh P; Singh R; Varma DS; Viramgami A; Panda S; Reddy DCS; Bhargava B;
Lancet Glob Health; 2021 Mar; 9(3):e257-e266. PubMed ID: 33515512
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of SARS-CoV-2 IgG and associated factors among people living with HIV over the first 12 months following the outbreak of COVID-19 in Burkina Faso, a sub-Saharan African country.
Kaboré OD; Poda A; Ouattara CA; Michodigni FN; Belem AA; Sawadogo Y; Zoungrana J; Galal L; Meda CZ; Godreuil S; Ouédraogo AS
PLoS One; 2023; 18(6):e0286665. PubMed ID: 37315090
[TBL] [Abstract][Full Text] [Related]
8. Trend in seroprevalence of SARS-CoV-2 (IgG antibody) among tribal-dominated population: Findings from Jharkhand, India.
Mahapatra A; Palo SK; Bhattacharya D; Kanungo S; Kshatri JS; Mishra BK; Mansingh A; Parai D; Pattnaik M; Choudhary HR; Dash GC; Mohanta AR; Bishoyee A; Mohanty P; Mandal N; Dayal R; Mitra A; Pati S
Indian J Med Res; 2022 Aug; 156(2):228-239. PubMed ID: 36629182
[TBL] [Abstract][Full Text] [Related]
9. The seroprevalence of COVID-19 in patients living with HIV in metropolitan Detroit.
Gudipati S; Lee M; Scott M; Yaphe S; Huisting J; Yared N; Brar I; Markowitz N
Int J STD AIDS; 2022 May; 33(6):554-558. PubMed ID: 35333100
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of SARS-CoV-2 Antibodies and the Impact of COVID-19 on the HIV Care Continuum, Economic Security, Risky Health Behaviors, and Mental Health Among HIV-Infected Individuals in Vietnam.
Matsumoto S; Nagai M; Luong DAD; Nguyen HDT; Nguyen DT; Van Dinh T; Van Tran G; Tanuma J; Pham TN; Oka S
AIDS Behav; 2022 Apr; 26(4):1095-1109. PubMed ID: 34570314
[TBL] [Abstract][Full Text] [Related]
11. Seroprevalence of anti-SARS-CoV-2 IgG antibodies in the staff of a public school system in the midwestern United States.
Lopez L; Nguyen T; Weber G; Kleimola K; Bereda M; Liu Y; Accorsi EK; Skates SJ; Santa Maria JP; Smith KR; Kalinich M
PLoS One; 2021; 16(6):e0243676. PubMed ID: 34111144
[TBL] [Abstract][Full Text] [Related]
12. High prevalence of SARS-CoV-2 antibodies in pregnant women after the second wave of infections in the inner-city of Johannesburg, Gauteng Province, South Africa.
Sawry S; Le Roux J; Wolter N; Mbatha P; Bhiman J; Balkus J; von Gottberg A; Cohen C; Chersich M; Kekana M; Ndlovu T; Shipalana A; Mthimunye W; Patel F; Gous H; Walaza S; Tempia S; Rees H; Fairlie L
Int J Infect Dis; 2022 Dec; 125():241-249. PubMed ID: 36347458
[TBL] [Abstract][Full Text] [Related]
13. SARS-CoV-2 seroprevalence and associated factors, based on HIV serostatus, in young people in Sofala province, Mozambique.
Benoni R; Casigliani V; Zin A; Giannini D; Ronzoni N; Di Chiara C; Chhaganlal K; Donà D; Merolle A; Dos Anjos HG; Chenene F; Tognon F; Putoto G; Giaquinto C
BMC Infect Dis; 2023 Nov; 23(1):809. PubMed ID: 37978353
[TBL] [Abstract][Full Text] [Related]
14. A cross-sectional study of SARS-CoV-2 seroprevalence among asymptomatic healthcare workers in a tertiary healthcare centre: Assessing the impact of PPE guidelines.
Wattal C; Oberoi JK; Goel N; Datta S; Raveendran R; Rao BK; Kumar R
Indian J Med Microbiol; 2021; 39(4):528-533. PubMed ID: 34688485
[TBL] [Abstract][Full Text] [Related]
15. Estimate of anti-SARS-CoV-2 spike IgG antibodies prevalence among Iranian population based on blood donations: A serial cross-sectional study during the third wave of the pandemic.
Ranjbar Kermani F; Arabkhazaeli A; Eshghi P; Maghsudlu M; Amini-Kafiabad S; Teimourpour A; Pourkarim MR
Transfus Clin Biol; 2023 Feb; 30(1):123-129. PubMed ID: 36084918
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of SARS-CoV-2 IgG antibodies in the staff of the Slovak Academy of Sciences in response to COVID-19 and/or vaccination: situation in August 2021.
Kajanova I; Lukacikova L; Jelenska L; Grossmannova K; Radikova Z; Vlcek M; Klempa B; Kollar R; Bodova K; Kopacek J; Pastorekova S
Acta Virol; 2021; 65(4):420-432. PubMed ID: 34796716
[TBL] [Abstract][Full Text] [Related]
17. Prevalence and associated characteristics of anti-SARS-CoV-2 antibodies in Mexico 5 months after pandemic arrival.
Díaz-Salazar C; Sánchez-García A; Rodríguez-Gutiérrez R; Camacho-Ortiz A; Saldívar-Rodríguez D; González-González JG
BMC Infect Dis; 2021 Aug; 21(1):835. PubMed ID: 34412620
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 seroprevalence and associated risk factors in periurban Zambia: a population-based study.
Shanaube K; Schaap A; Klinkenberg E; Floyd S; Bwalya J; Cheeba M; de Haas P; Kosloff B; Ruperez M; Hayes R; Ayles H
Int J Infect Dis; 2022 May; 118():256-263. PubMed ID: 35306205
[TBL] [Abstract][Full Text] [Related]
19. SARS-CoV-2 Infection Is Associated with Uncontrolled HIV Viral Load in Non-Hospitalized HIV-Infected Patients from Gugulethu, South Africa.
Lambarey H; Blumenthal MJ; Chetram A; Joyimbana W; Jennings L; Tincho MB; Burgers WA; Orrell C; Schäfer G
Viruses; 2022 Jun; 14(6):. PubMed ID: 35746693
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seroprevalence in healthcare workers in a high-volume ophthalmology centre in Guatemala.
Davila-Siliezar P; Wer A; Barnoya J
Ann Med; 2021 Dec; 53(1):1956-1959. PubMed ID: 34727801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
